We've updated our Privacy Policy. Questions? Email us any time at privacy@ground.newsWe've updated our Privacy Policy with additional info on research surveys, our browser extension, cookie management, and ad performance measurement. Questions? Email us any time at privacy@ground.news
Telos said it will discuss second-quarter results and full-year guidance in a webcast, with executives taking questions after the presentation.
On Wednesday, August 12, 2026, shares of Quanterix plummeted 39% after the company issued a revised financial outlook, marking a significant market correction for the diagnostic firm.
A shift in profitability targets to 2027 caused the market sell-off, as investors adjusted expectations for the firm's financial trajectory following the announcement.
Management cited operational challenges and increased costs as the primary drivers for the extended timeline to reach breakeven, indicating broader hurdles in adoption.
Immediate market revaluation followed the news, reflecting heightened scrutiny regarding cost management and the firm's ability to scale operations.
Success in hitting the new financial goals will be critical for restoring shareholder confidence in the company's business model and its long-term path to sustainable growth.